Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KNiT trial for injection therapy in knee osteoarthritis
2021-000180-70Phase 4Terminated
- Sponsor
- Beacon Hospital
- Start
- Feb 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of methylprednisolone and bupivacaine in knee osteoarthritis (OA) (3 arms), sponsored by Beacon Hospital. Primary endpoint: WOMAC score. Started Feb 2021; status: terminated.
02
Drugs
methylprednisolonebupivacaine
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2021-000180-70.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-000180-70.